| Study |
Study type |
Year |
Country |
Objective |
Comparative group |
Conclusion/outcome |
| Curley et al. [3] |
Randomized controlled trial |
2019 |
England |
To provide evidence concerning the thresholds associated with conducting platelet transfusions |
Preterm infants |
Defined transfusion thresholds that reduce mortality without increasing risk |
| Davenport et al. [4] |
Cohort study |
2024 |
The United States |
Examine platelet transfusion mechanisms and approaches |
Standard treatment |
Association of transfusions with mortality and neurodevelopmental impairment |
| Liu et al. [2] |
Systematic review protocol |
2020 |
China |
To assess issues associated with blood transfusion among neonates |
Platelet transfusion among patients with thrombocytopenia |
Protocol development for systematic review on neonatal thrombocytopenia |
| Moore et al. [5] |
Randomized controlled trial |
2023 |
Ireland, the UK, and the Netherlands |
Examine mortality and neurodevelopmental issues among neonates who underwent transfusion |
Standard treatment |
Improved neurodevelopmental outcomes at two years post-transfusion |
| Ribeiro et al. [1] |
Systematic review and meta-analysis |
2023 |
Europe |
To explore facts concerning platelet transfusion outcomes |
Non-transfused infants |
Identified controversies in current transfusion practices |
| Sola‐Visner et al. [6] |
Randomized controlled trials |
2022 |
The United States |
The study assesses the effectiveness of conducting platelet transfusions among neonates |
Adult platelets |
Challenges in translating evidence-based recommendations into practice |
